Get started

Nasdaq

NASDAQ: Technology Leads Amid Challenges and OpportunitiesNASDAQ: Technology Leads Amid Challenges and Opportunities The NASDAQ index remains a focal point for investors, driven by the strength of technology and artificial intelligence (AI) stocks, while navigating regulatory hurdles and mixed economic data. Here's a closer look at the factors shaping the index's performance and its outlook for the coming weeks. --- Key Factors Driving NASDAQ Tech Rally and AI Optimism NASDAQ has seen robust gains, fueled by the dominance of tech stocks. Investors continue to bet on the long-term potential of AI, boosting companies like Microsoft and Meta. However, Microsoft faces regulatory scrutiny from the FTC over its AI software sales, which could weigh on short-term performance. Meanwhile, Meta, led by Mark Zuckerberg, is adapting its strategies to align with the evolving political landscape, including engagement with the Trump administration's policies. Strong Corporate Performance - Salesforce reported Q3 revenue of $9.44 billion, exceeding expectations, though adjusted EPS disappointed. - Microsoft and other tech giants continue to invest heavily in AI, supporting long-term investor optimism. Despite some challenges, the technology sector remains a key growth driver for NASDAQ, supported by innovation and strong demand for digital products and services. --- Macroeconomic Data and NASDAQ Mixed Signals from the U.S. Economy - ISM Services PMI fell to 52.1, below expectations of 55.7, indicating slower growth in the service sector, a key driver of consumer demand for technology. - Durable goods orders rose 0.3%, meeting expectations and signaling economic stability. - Construction spending increased by 0.4%, reflecting robust investment activity. While these figures present a mixed picture, stability in other areas, such as the labor market (JOLTS job openings at 7.744 million in October), provides a solid foundation for the market. Federal Reserve Policy and Its Impact on Technology The Federal Reserve is slowly pivoting toward a more dovish stance. An anticipated rate cut in December, currently priced at a 74% likelihood, could benefit technology stocks, which are sensitive to borrowing costs. The Fed forecasts gradual disinflation toward a 2% target by 2025, potentially creating favorable conditions for the tech sector in the long term. --- Seasonality and NASDAQ December has historically been a strong month for tech-heavy indices like NASDAQ, driven by: - Seasonal consumer spending, particularly on electronics and digital services. - End-of-year portfolio rebalancing by investors. - Optimism surrounding technological advancements and innovations. The **Fear & Greed Index**, currently at 56, indicates a sentiment skewed toward greed, often a precursor to further short-term market gains. --- NASDAQ Outlook: Technology at the Forefront As a leader in the technology space, NASDAQ has strong fundamentals to end the year on a high note. Robust demand for AI-related technologies, stable economic data, and Federal Reserve support create a positive backdrop for the index. However, investors must remain cautious about potential risks, including: - Regulatory challenges for tech giants. - Geopolitical tensions impacting global supply chains. - Uneven progress in disinflation, which could prolong restrictive monetary policies. With optimism surrounding technology and potential monetary easing, NASDAQ remains an attractive choice for long-term investors. However, key events such as quarterly earnings and further Federal Reserve decisions will significantly influence the index's trajectory. For now, the tech rally seems well-supported, but vigilance is essential.
CAPITALCOM:US100Long
by InvestMate
Nasdaq Intraday Review - Wednesday 4 Dec 2024I trade Nasdaq exclusively Trading in GMT time zone Sharing my post day review and analysis in case it can help you! Did my analysis at +- 5:30 am GMT (00:30 am EST) Economic news - ADP Nonfarm Employment Change @13:15 News - None Directional bias - BUY Morning analysis: M TF - very bullish W TF - very bullish, we are now in all time high territory again D TF - D candle had closed higher that previous high, testament of the bullish sentiment 4H TF - very bullish, 4H EMA is far down, so if price retraces it could be a long way down before price finds the dynamic support of the 4H EMA As the day progressed: Noted a rising wedge pattern form as marked by the blue lines. Price broke the market pattern upwards and came back down to retest the top line of the pattern. With price being at an all time high, it could easily be assumed that price will make a huge retracement. In the past, I would have been eagerly ready to place a sell because it's at an all time high and "has to come down"(*). I have lost a lot of money in the past, trying to decide for the market, what it should do. Looking at this market pattern, the way price broke upwards, re-tested and closed a green candle HIGHER. It seemed to me price wanted to continue upwards. From years of screen time, I also know that if price is very bullish (like at all time highs) it can continue higher for much longer than one would expect. I have also seen that sometimes, price will continue to push for the previous day's TP's. So because price was also rejecting the TP1 from the day before and closing higher, I felt that bulls wanted to push for TP2. I entered a small buy position at the hand icon. Price shot all the way up to TP2. I closed just before market open at the top hand icon and made a cool 870 pips. I closed because I was "sure" market open would retrace and wanted to lock in my profits. So even though preaching at (*) in the text above, I was still a victim of this mentality that "price has to come down" :) But anyway, I am still happy with my trading today. In the long ago past, I probably would have taken a sell just because price "has to come down after all time high". In the not-so-long-ago past, I probably would have sat out and been too scared to take a buy, even though I saw the signal. But today, I took the signal, albeit with a small position. #progress So just a reminder, trading is a long and slow game of patience and repetition (or at least for me). Keep going, keep consistent and you will see progress. In the beginning your goal should be to survive and live to trade another day. Get in as many hours of screen time as you can...and just keep going. ​If I were to advise a beginner, I would say: 1. Learn as much as you can about candles, market patterns and timeframe confluence (use baby pips.com for an excellent free resource) 2. Have 3 x display screens on your desk. On one screen, have the 1H TF displayed, on the second screen, display a split between the 4H TF and the D TF. On the third screen, display a split between the 15min and 30min TF. 3. Stare at your screens for hours and hours a day! Haha! Screen time is the most valuable experience you can get. 4. Don't demo trade for too long. Trading with real money changes the game. So trade with the smallest possible position size available eg. 0.01 and just try to survive to the next day. 5. Start seeing results after a few years (not what everyone wants to hear because trading is "fast, easy money", but that is the truth for the majority of traders) ​All the best! :) Stats: The total move for the day was 2'000 pips I captured 870 pips / 44 % of the total move (need to improve) Abbreviations: TF = timeframe TP = take profit 1H = 1 hour 4H = 4 hour D = day W = week M = month S&R = support & resistance H&S = head & shoulders EMA = exponential moving average SL = stop loss
PEPPERSTONE:NAS100
by Jinxx84
Investors Update for BloomZ Inc. (Dated 4th December 2024)BloomZ Inc. , a leading name in Japanese anime production, audio production, and voice actor management, has recently unveiled several strategic initiatives and completed notable projects that reinforce its industry standing and growth trajectory. These developments underscore the company’s commitment to innovation and value creation for its stakeholders. One of the most significant announcements is BloomZ’s new strategic partnership with Badge Inc., a cutting-edge fan engagement solutions provider. This collaboration aims to revolutionise the fan experience by integrating Badge’s advanced technologies with BloomZ’s extensive content portfolio. The partnership will provide fans with innovative avenues to interact with their favourite anime characters and VTuber personalities, enhancing the overall audience engagement. This move not only aligns with evolving market trends but also sets a benchmark for fan interaction in the anime and digital entertainment space. Additionally, BloomZ has solidified its presence in the digital entertainment domain through its alliance with CrossVision Inc. , a company renowned for its expertise in Web 3.0 technologies. This partnership seeks to blend BloomZ’s proficiency in animation and VTuber management with CrossVision’s blockchain and metaverse capabilities. Together, the companies are exploring groundbreaking initiatives, including metaverse fan events and blockchain-based fan engagement solutions, which have the potential to redefine industry standards and expand BloomZ’s market reach. On the production front, BloomZ has successfully completed audio production for two highly anticipated anime series: Maou-sama, Retry! R and Goodbye, Dragon Life – Hello, Human Life. These projects, which aired in October 2024, have already garnered widespread acclaim. With original light novels boasting impressive sales figures of 2.22 million and over 1 million copies, respectively, these anime adaptations are expected to further solidify BloomZ’s reputation for delivering high-quality sound production. These achievements highlight the company’s dedication to excellence and its pivotal role in bringing popular narratives to life. As BloomZ continues to build on its strong foundation, the company is proactively exploring collaborations with additional strategic partners. By engaging with innovative entities and leveraging emerging technologies, BloomZ remains committed to driving growth, enhancing shareholder value, and shaping the future of anime and digital entertainment.
NASDAQ:BLMZLong
by HASHInvests200
USNAS100 / Key Breakout Levels and Trend ProjectionsTechnical Analysis The price surged approximately 320 pip, as anticipated in our previous analysis. Today, maintaining stability above the All-Time High (ATH) is crucial to achieving further gains, with the next target at 21,360. A confirmed 1-hour or 4-hour candle close above 21,215 would likely drive the price toward 21,360 and further to 21,500. Conversely, if the price stabilizes below 21,160 with a confirmed 1-hour or 4-hour candle close, a decline toward 21,075 and 20,990 is expected. Key Levels: Pivot Point: 21160 Resistance Levels: 21220, 21360, 21500 Support Levels: 21075, 20990, 20860 Trend Outlook Bullish: Upon breaking and closing above 21,215. Bearish: Upon breaking and stabilizing below 21,160. PREVIOUS IDEA:
OANDA:NAS100USDShort
by SroshMayi
Nasdaq Intraday Review - Tuesday 3 Dec 2024I trade Nasdaq exclusively Trading in GMT time zone Sharing my post day review and analysis in case it can help you! Did my analysis at +- 5:30 am GMT (00:30 am EST) Economic news - JOLTS job openings @ 15h00 News - None Directional bias - BUY Morning analysis: M TF - Very bullish W TF - Very bullish, but at a strong resistance now. Price will need to break the prior week's highest close. D TF - Very bullish, yesterday's candle closed right at the weekly resistance 4H TF - Doji candle formed exactly on the W resistance but subsequent candles closed above. This doji level would be a good place for a mental stop loss because if candles start closing below this point, market could retrace. 4H 0.382 fib level (fib drawn from swing low at A to swing high at B.) + pivot point is far down...nearly 1000 pips from price (at time of writing at 5:49am). That's a long way down! Don't want to get into a deep drawdown situation. 30min TF - Ascending triangle forming (marked in orange lines). The resistance caused by the previous highest 4H candle close is holding candles down. But ascending triangles usually break upwards, as pressure mounts from bulls against the resistance level (although these market patterns can break either way). 2 x interest zones / areas of confluence identified: 1. Highest green highlighted area = pivot point + 4H 0.382 buy fib level 2. Lowest highlighted green area = This zone moved throughout the day at the 4H EMA moved, but eventually I settled on where it is marked now i.e. 4H EMA (at some point during the day) + 4H 0.618 buy fib level As the day progressed: Ultimately the ascending triangle broke downwards and a temporary downtrend line started forming as marked by the pink line. This line held down many candles but eventually was broken on the 15min TF and I entered a buy at the top hand icon - Confirmations: 1. Market pattern - DB formed on the 15min TF, with neckline broken upwards + also breaking the temporary down trend line. The ascending wedge market pattern profit target had also just about been met (price usually travels the same distance as the height of the market pattern once the market pattern is broken - marked with the orange vertical line) 2. S&R - seemed as though the 1H EMA was providing dynamic support 3. Trend - temp down trend was broken (price had crossed the pink line) and my buy was in the same direction as the overall trend - The trend is your friend. 4. Fib - small 1H fibs were being adhered to, but didn't really consider this as part of my confirmation 5. Candlesticks - None really Mental SL was placed at the thick pink line at about half the height of the DB. Unfortunately, price could not remain above the pink down trend line on the higher TFs and price moved down. I closed as the 15min candle closed below my stop loss. Took a loss of 250 pips, which I consider to be small and of no real consequence. I don't regret this entry, it was worth a try and the SL was tight, so not a lot to risk. Second buy entry was at blue arrow icon - Confirmations: 1. Market pattern - price had touched my green area of confluence and so I moved to the 5min TF where a DB formed and I entered on the break of the neckline upwards 2. S&R - pivot point 3. Trend - buy is in the same direction as the overall trend 4. Fib - DB formed just above the 4H 0.382 fib level 5. Candlesticks - long wicks down to the pivot point indicate that buyers are rejecting this zone and stepping in at this price level. ​ Mental SL was placed below the green area of confluence. ​ Price moved up, more than 250 pips from my entry and I secured at entry. Unfortunately, price moved back down and took me out at entry. Although I was ultimately right with my entries and direction....price was just to spiky for me today. I stepped away from my screens for a few mins at 16h00 and missed a nice entry at C. where price broke the falling wedge pattern that ultimately formed on the 1H TF (between the pink and blue lines). Was a bit bummed that I missed that one. So ultimately for me, I closed the day with a small loss, today was just too spiky for my trading system. Not complaining though because my risk was managed and I live to trade another day - "No Risk, No Magic" Hope you had a better day! :) Abbreviations: TF = timeframe TP = take profit 1H = 1 hour 4H = 4 hour D = day W = week M = month S&R = support & resistance H&S = head & shoulders EMA = exponential moving average SL = stop loss
PEPPERSTONE:NAS100
by Jinxx84
NASDAQ – Solid Foundation Amid Positive Economic DataNASDAQ – Solid Foundation Amid Positive Economic Data The NASDAQ index is finding strong support from favorable U.S. economic data and a stable macroeconomic outlook, particularly benefiting from the resilience of technology and growth sectors. Amid signs of moderating inflation and potential easing by the Federal Reserve, **seasonal trends strongly favor the NASDAQ, as December is historically a strong month for equities, especially tech-heavy indices. --- Key Economic Drivers Supporting the NASDAQ 1. ISM Manufacturing PMI – Signs of Stabilization - The **ISM Manufacturing PMI** for November rose to **48.4**, exceeding expectations, though still signaling contraction. This reflects progress toward stabilization in the U.S. manufacturing sector. - Slower input cost inflation and renewed job creation are positive signs for the broader economy, indirectly supporting growth-oriented sectors such as technology. 2. Construction Spending Growth - Construction spending** increased by **0.4% in October, showcasing resilience in the housing and infrastructure sectors. This strength in spending highlights consumer and government investment, which can indirectly benefit tech companies involved in digital infrastructure and smart technologies. 3. ISM Manufacturing Prices Paid – Easing Inflationary Pressures - The ISM Manufacturing Prices Paid** index dropped to **50.3**, significantly below the forecast of **55.2**. This is a positive development for inflation control, signaling moderating cost pressures in the manufacturing sector. - Implications: - Positive for equities: Lower inflation reduces the likelihood of aggressive Federal Reserve rate hikes, a scenario that benefits rate-sensitive growth stocks. - Stable monetary outlook: A gradual shift toward easing monetary policy supports technology stocks reliant on lower borrowing costs. 4. Fed Officials’ Support for Gradual Easing - Recent Fed commentary suggests a balanced approach to monetary policy: - **Christopher Waller** emphasized the possibility of a rate cut in December, citing a balanced labor market and controlled inflation progress. - **John Williams** forecasted GDP growth of **2.5% in 2024** while reiterating that inflation is expected to return to the 2% target. This fosters confidence in growth-oriented sectors like technology. - A potential rate cut would be particularly favorable for the NASDAQ, as tech companies are highly sensitive to changes in interest rates. 5. Consumer and Business Optimism - The **S&P Global U.S. Manufacturing PMI** indicated improving confidence and renewed job creation despite lingering challenges such as reduced international demand. This optimism supports steady sentiment for growth sectors. --- Seasonality and Market Sentiment Seasonality is a critical tailwind for the NASDAQ at this time. December is traditionally a strong month for the tech-heavy index, supported by holiday-driven consumer spending, portfolio rebalancing, and end-of-year tax strategies. The current **Fear & Greed Index**, standing at **64**, indicates a **greed-driven sentiment**, which typically aligns with upward momentum, especially for high-growth sectors. --- NASDAQ Outlook The NASDAQ is well-positioned to capitalize on these favorable conditions: - Easing inflationary pressures reduce the likelihood of aggressive Federal Reserve tightening, which is particularly supportive for rate-sensitive growth stocks. - Strong GDP growth projections and a resilient labor market provide a stable foundation for tech earnings and innovation-driven sectors. - Seasonal trends, combined with improving macroeconomic sentiment, create additional momentum for the NASDAQ as the year-end approaches. While global uncertainties and international demand challenges remain, the NASDAQ's long-term prospects remain **bullish**. Seasonal strength, positive economic data, and the potential for a more accommodative Fed policy stance are all aligning to favor continued gains for the index.
CAPITALCOM:US100Long
by InvestMate
NASDAQ Santa rally is starting.Nasdaq (NDX) has been following the blueprint of the 2020/21 Bull Cycle to high precision so far, as we showed on our analysis almost 4 months ago (August 19, see chart below): As you can see it is already marching towards Target 1 (23250) on the 0.236 Fibonacci retracement level, well inside the Channel Up. We expect that to get hit by the final week of December, which can be translated as the infamous 'Santa rally', a frequent seasonal price increase at the end of the year. As mentioned, this Channel Up displays strong similarities with the patterns of August 2020 - November 2021 and before the COVID crash of December 2019 - February 2020. All those Channel Up patterns are within the dominant long-term structure of the 6-year Bullish Megaphone. The key here is for the 1W MA50 (blue trend-line) to hold and continue to offer support, as within those 6 years the only two times it broke were during the corrections of the 2022 Inflation Crisis and the March 2020 COVID flash crash. As long as it holds, the current Channel Up should, besides the immediate Target 1 (23250), complete the sequence and peak towards the end of 2025 as close to a +185% rise (from the October 2022 bottom) as possible. This is why our long-term strategic Target (2) is a little lower at 27000. As a side-note, see how well the 1W RSI held and bounced in September on the Symmetrical Support Zone, in similar fashion as 2020 - 2021. Also the 1W MACD displays a similar pattern between the two fractals. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:NDXLong
by TradingShot
1
Corcept Therapeutics: A Shining Star in US BiotechCorcept Therapeutics is making waves in the booming U.S. biotech scene, with its stock surging 46.2% over the past six months. The company, known for its Cushing's syndrome drug, Korlym, reported a staggering 39.1% year-over-year sales increase, reaching $310.6 million in H1 2024. With a market cap of $4.42 billion, Corcept is actively developing new treatments like Relacorilant, which shows promise in clinical trials. Despite a high PE ratio of 35.3x compared to the industry average of 19x, its strong revenue growth and commitment to R&D position it as a solid investment opportunity in the fast-growing biotech market projected to reach $1,786 billion by 2033. ◉ The US Biotech Industry Outlook The biotech boom in the U.S. is hotter than a California summer! Fueled by groundbreaking tech and government cheerleading, the industry is soaring higher than a SpaceX rocket. According to Vision Research Reports, the market is projected to soar by 12.4% CAGR from 2024 to 2033. This rapid expansion is driven by advancements in areas like genomics, gene editing, and personalized medicine, positioning the U.S. as a global leader in healthcare innovation. ➖ The US biotechnology market size was valued at $552.43 billion in 2023 and is anticipated to hit around $1,786 billion by 2033. ➖ Key players like Abbvie Inc., Genentech Inc., and Amgen Inc. are leading the market. Acknowledging the remarkable expansion of the biotech sector, we are taking a closer look at a stock that is showing considerable strength in its technical chart, complemented by robust financial performance. ◉ Company Overview Corcept Therapeutics NASDAQ:CORT is a biopharmaceutical company dedicated to developing innovative treatments for severe endocrine, oncologic, and metabolic disorders. Their lead product, Korlym, is approved for Cushing's syndrome, a rare endocrine condition. Corcept is also advancing several pipeline candidates, including relacorilant for Cushing's syndrome, treatments for various cancers, and potential therapies for neurological conditions like amyotrophic lateral sclerosis and nonalcoholic steatohepatitis. Founded in 1998, Corcept is based in Menlo Park, California. ◉ Significant Stock Performance of Corcept Therapeutics Corcept Therapeutics Incorporated's stock price has risen 46.2% in the past six months, despite a 2% industry decline. This surge is attributed to strong demand for Korlym, the company's sole marketed drug used to treat Cushing's syndrome, a condition that is primarily cured with mifepristone. ◉ The Economic Impact of Korlym The primary source of revenue for Corcept emanates from the sales of Korlym. The drug has showcased remarkable growth, evidenced by a 39.1% year-over-year sales increase, culminating in $310.6 million during the first half of 2024. This growth is attributed to robust demand and an unprecedented number of patients being prescribed the medication. ◉ Corcept's Stock Growth Factors ● Potential of Relacorilant: Positive GRACE study results suggest relacorilant could be a valuable treatment for Cushing's syndrome, potentially driving revenue growth. ● Pipeline Diversification: Corcept's ongoing exploration of relacorilant in GRADIENT study demonstrates commitment to expanding pipeline. ● Regulatory Progress: Successful completion of GRACE study positions Corcept for a new drug application in late 2024. ● Market Need: Successful relacorilant could fill significant unmet medical need for Cushing's syndrome. Investent Advice by Naranj Capital Buy Corcept Therapeutics NASDAQ:CORT ● Buy Range- 38 - 40 ● Target- 55 - 58 ● Potential Return- 35% - 40% ● Invest Duration- 12-14 Months ◉ Market Capitalization - $4.42 B ◉ Peer Companies ● Prestige Consumer Healthcare NYSE:PBH - $3.644 B ● Jazz Pharmaceuticals NASDAQ:JAZZ - $6.766 B ● Amphastar Pharmaceuticals NASDAQ:AMPH - $2.423 B ● Organon NYSE:OGN - $5.142 B ◉ Relative Strength ➖ The chart distinctly demonstrates that NASDAQ:CORT has significantly surpassed the US Smallcap 2000 index, attaining an impressive annual return of 30%, marking a remarkable accomplishment. ◉ Technical Aspects ● Monthly Chart ➖ The historical chart shows that the stock price is trending upward, marked by a sequence of higher highs and higher lows. ➖ Having recently moved out of the parallel channel, the price is set for additional gains. ● Daily Chart ➖ After an extended period of consolidation, the stock price has formed an Inverted Head & Shoulders pattern. ➖ Post-breakout, the stock has stabilized above the breakout point and is now striving for new highs. ➖ A surge in trading volume suggests that buyers are currently showing significant interest. ◉ Revenue & Profit Analysis ● Year-on-year ➖ In the fiscal year 2023, revenue experienced a significant increase of 20.4%, amounting to $482.4 million, compared to $401.9 million in fiscal year 2022. ➖ However, EBITDA faced a downturn, decreasing to $108.3 million in FY23 from $113.9 million in FY22. ➖ The EBITDA margin also saw a reduction, falling to 22.46% from 28.34% in FY22. ➖ Moreover, diluted earnings per share (EPS) rose by 8% year-over-year, climbing to $0.94 in FY23, up from $0.87 in FY22. **While the growth in EBITDA might raise some concerns, it's crucial to acknowledge that the company is heavily investing in its research and development sector, and this investment has seen substantial increases over the years. ● Quarter-on-quarter ➖ In the most recent June quarter, the company reached an impressive achievement, with quarterly sales hitting a record high of $163.8 million. This represents a 12% increase from the $146.8 million reported in the March quarter and a substantial 39% growth compared to $117.7 million in the corresponding quarter of the previous year. ➖ Additionally, EBITDA rose from $29.6 million to $36.2 million during the latest quarter. ◉ Valuation ◉ PE Ratio ● PE vs Median PE ➖ Corcept Therapeutics sustained a median price-to-earnings ratio of 19.7x from December 2019 to 2023. ➖ Presently, with a price-to-earnings ratio of 35.3x, the stock seems to be relatively expensive. ● PE vs. Peers PE ➖ CORT's Price-To-Earnings Ratio stands at 35.3x, making it quite pricey when compared to the average of its peers, which is only 13.6x. ● PE vs. Industry PE ➖ CORT's valuation seems high, as it has a Price-To-Earnings Ratio of 35.3x, which is considerably above the US Pharmaceuticals industry average of 19x. ◉ PB Ratio ● PB vs. Peers PB ➖ The current price-to-book (P/B) ratio suggests that the stock is slightly undervalued, sitting at 7.4x compared to the peer average of 10.8x. ➖ However, it's important to note that a P/B ratio of 7.4x is typically seen as significantly overvalued. ● PB vs. Industry PB ➖ When we analyze the P/B ratio against the industry standard, CORT stands out as being notably overvalued, with its P/B ratio of 7.4x far exceeding the industry average of just 1.7x. ● PEG Ratio ➖ The stock currently seems to present a compelling investment opportunity, featuring a PEG ratio of 0.84. ◉ Cash Flow Analysis ➖ In FY23, operating cash flow increased to $127 million, compared to $120.3 million in FY22. However, it's essential to recognize that when examining the overall trend from FY19 to FY23, there has been a decline in cash flow from operations. ◉ Debt Analysis ➖ CORT operates without any debt, showcasing the robust financial health of the company. ◉ Top Shareholders ➖ Blackrock presently possesses a significant 15.8% ownership in this stock, while The Vanguard Group maintains approximately 9.1% stakes. ◉ Conclusion Following a comprehensive examination of technical and fundamental metrics, our assessment indicates that Corcept Therapeutics possesses substantial growth potential within the US biotechnology sector. Notwithstanding elevated valuations, the company's increasing research and development expenditures demonstrate a strong commitment to its future prospects. Consequently, we consider Corcept Therapeutics a prudent investment choice at this juncture.
NASDAQ:CORTLong
by NaranjCapital
Nasdaq Intraday Review - Monday 2 Dec 2024I trade Nasdaq exclusively Trading in GMT time zone Sharing my post day review and analysis in case it can help you! Did my analysis at +- 5:30 am GMT (00:30 am EST) Economic news - None News - None Directional bias - BUY. All higher timeframes are bullish. Morning analysis: M TF - November candle closed very bullish. Candle body is +- 9'600 pips. Indicates very bullish sentiment overall W TF - Last week's candle closed in a doji formation. Could be an indication that bulls are loosing momentum D TF - Fridays candle closed right at the resistance formed by Tuesday's candle. Could Friday's candle represent the second top of a DT? Neckline would be 1'700 pips down (at time of writing). But D EMA is right at neckline, so bears would have to push very hard to break this neckline down. In the past I have noted that when we have 2 x days, like Thanksgiving, where market was closed / half day, we see a COMPLETELY different sentiment come in on market open of the first "real" day of trading. It's like the extended trading guys where doing their own thing (in this case being bullish) and then when real market comes in, sentiment could be much different and a correction could occur. So need to be careful at market open. 2 x areas of interest identified (highlighted in green) 1. 1H + 4H 0.382 buy fib level + Pivot point + D 0.618 SELL fib level which bulls will want to stay above + 1H EMA (at time of writing at 6am) 2. D EMA (at time of writing at 6am) + W 0.382 buy fib + D 0.618 buy fib level As the day progressed: Entered a buy at the hand icon - Confirmations: 1. Market pattern - Price made a DB before reaching the first interest area. DB on the 1H TF with neckline broken upwards. The second bottom of the DB (at C.) is higher than the first bottom of the market pattern. This also contributes to the bullishness of the market pattern. Entered on the break of the neckline at the hand icon. 2. S&R - candle wicks touching 30 EMA and moving up (at time of writing in the morning), i.e. 30min EMA providing dynamic support. 3. Trend - Temporary down trend line broken (marked with top green line), indicating that the downtrend is over and price is ready to resume upwards. 4. Fib - A few wicks reaching towards the 4H 0.382 fib, but DB formed quite a way above this level. 5. Candlesticks - candle wicks touching 30 EMA and moving up, i.e. 30min EMA providing dynamic support. Mental SL placed at the thick pink line. Usually, I would place my stop loss at half the height of the market pattern but because this was such a tight DB, I felt I have to place it a bit lower where the first bottom occurred. If candles started closing below this point, I would consider closing. I opened a full position size and it was a banger of a day! Market open pushed straight up! Price ultimately moved 2979 pips from my entry. I closed when price made a DT on the 15min (indicated at the top hand icon). I would normally leave a runner, but I am on a mission to build my account and so don't want to leave money on the table. Made some good moola today! Hope you did too! Laters! Stats: Price moved a total of 3195 pips today. Of the total move, I captured 2651 pips / 83%. Abbreviations: TF = timeframe TP = take profit 1H = 1 hour 4H = 4 hour D = day W = week M = month S&R = support & resistance H&S = head & shoulders EMA = exponential moving average SL = stop loss
PEPPERSTONE:NAS100
by Jinxx84
2024-12-02 - priceactiontds - daily update - nasdaqGood Evening and I hope you are well. nasdaq e-mini futures comment: Clear breakout on the daily chart. ATH wants a retest and for now there is no reason why market would stop there. My upmost target is 22400ish but for now bulls want to hit the 3 upper trend lines and see which one produces most resistance. Bears come back into the picture with a daily close below 20800. current market cycle: Bull trend but also nested bull wedges on the daily chart. Will end in the next 3-8 weeks key levels: 21000 - 21500 bull case: Bulls have 3 obvious targets above now. First ath retest 21340, then 2 more upper bull trend lines from wedges. 22000 is possible over the next 4 weeks but we are in the last stage of the bull trend. Invalidation is a daily close below 21000. bear case: Bears gave up above 21000 and will probably try again above 20300 or higher. For now they don’t have any arguments before bulls begin to stall due to profit taking. It’s too late for bigger longs and too early to short. Be patient. Invalidation is above 22000. short term: Bullish for 21340 and then probably some more. Buying pullback is most likely the easiest way here. medium-long term: Will update this over the weekend. 22000 is a possibility but a bit far for now. Daily close above 20500 would bring it in play. First target for Q1 2025 is 19000. current swing trade: Nope trade of the day: Buy anywhere. Textbook breakout and market never looked back.
CME_MINI:MNQ1!Long
by priceactiontds
NASDAQ: Strong bullish breakout today targeting 21,600Nasdaq is bullish on its 1D technical outlook (RSI = 61.836, MACD = 123.620, ADX = 32.041) as today posted the strongest 1D candle since Nov 7th, extending the new bullish wave. The whole sequence is supported by the 1D MA50 since September 12th. Even though we are technically more than halfway through the wave, this is still a strong buy opportunity, aiming for a +6.80% rise (TP = 21,600) as it has previously done so inside the 3 month Channel Up. See how our prior idea has worked out: ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
CAPITALCOM:US100Long
by InvestingScope
USNAS100 - Bullish Momentum and Potential Reversal LevelsTechnically: The price experienced upward momentum on Friday and maintains its bullish trajectory, with stability observed above the critical level of 20,860. Bearish Scenario: A sustained break below 20,860 could trigger further declines, with potential targets at 20,730 and 20,600. Bullish Scenario: As long as the price remains above 20,860, the bullish outlook remains intact, paving the way toward 20,990. A breakout above this level may propel the price to an all-time high of 21,230. Notably, a retest of the 20,860 level from the current price is a plausible scenario. Key Levels: Pivot Point: 20860 Resistance Levels: 20990, 21080, 21230 Support Levels: 20730, 20660, 20550
OANDA:NAS100USDLong
by SroshMayi
AST SpaceMobile (ASTS) Analysis Company Overview: AST SpaceMobile NASDAQ:ASTS is pioneering a global space-based cellular broadband network, enabling mobile connectivity in remote and underserved areas. Its BlueBird satellite technology and strategic partnerships position ASTS as a disruptor in satellite communications. Key Growth Drivers: BlueBird Satellite Deployment: Successful launch of the first five BlueBird satellites demonstrates AST’s ability to deliver innovative mobile broadband solutions globally. This milestone positions the company to begin revenue generation through early adoption and partnerships. Space Development Agency (SDA) HALO Program: AST’s selection for the Highly Agile and Low Orbit (HALO) program opens a significant opportunity in the government and defense sectors. This collaboration may lead to diversified revenue streams and further innovation in secure satellite communications. Network Expansion Plans: Agreements for up to 60 additional satellite launches in 2025-2026 will drive subscriber growth, enable broader network coverage, and accelerate revenue generation. Strategic Partnerships and Investments: Backing from industry giants like AT&T, Verizon, Google, and Vodafone highlights ASTS’s credibility and potential to reshape the global communications market. These partnerships may also enhance access to established customer bases, supporting rapid scaling. Investment Outlook: Bullish Stance: We are bullish on ASTS above $19.50-$20.00, driven by its transformative technology, strategic partnerships, and extensive market opportunities. Upside Target: Our price target is $40.00-$42.00, reflecting ASTS’s potential to capture a substantial share of the growing satellite broadband market. 🚀 AST SpaceMobile—Connecting the World, Beyond Boundaries! #SpaceTech #ASTS #SatelliteRevolution
NASDAQ:ASTSLong
by Richtv_official
Nasdaq Modest Gains Amid Mixed Data and Rising OptimismNasdaq Modest Gains Amid Mixed Data and Rising Optimism The market’s performance reflects ongoing digestion of mixed US economic data, supportive seasonality, and cautious optimism among investors. US Economic Data Highlights Recent economic data provided a mixed picture of the US economy, driving market fluctuations: - **Chicago Fed National Activity Index (Oct):** Fell to -0.40, below the expected -0.2. - **Dallas Fed Manufacturing Index (Nov):** Came in at -2.7, worse than the forecast of -2.4. - **New Home Sales (Oct):** Declined to 0.61M, significantly missing expectations of 0.73M. - **Richmond Fed Manufacturing Index (Nov):** Plunged to -14, below the forecast of -10. - **Durable Goods Orders (Oct):** Increased by just 0.2%, underperforming the 0.5% forecast. - **Initial Jobless Claims (Nov 23):** Reported at 213K, slightly better than expected (216K), but still pointing to a resilient labor market. - **Chicago PMI (Nov):** Dropped to 40.2, well below the anticipated 44, highlighting weakness in manufacturing. Market Sentiment and Seasonality Seasonality continues to work in favor of the Nasdaq, as historical trends during this time of year often support equities. The **Fear & Greed Index**, currently at **66 points**, indicates moderate optimism and a "Greed" sentiment, encouraging risk-on behavior among investors. Rate Cut Expectations Markets remain focused on the Federal Reserve’s upcoming meeting on **December 18th**, with a **62,2%% probability** currently priced in for a **25 basis-point rate cut**. Such a move could provide additional support for equities by easing financial conditions, though its long-term impact remains uncertain. Geopolitical Risks Despite today’s recovery, geopolitical risks linger in the background. The ongoing war in Ukraine remains a significant concern, with potential implications for global energy prices, supply chains, and economic stability. Long-Term Trend Intact, but Volatility May Persist The Nasdaq’s long-term upward trend remains intact, supported by strong fundamentals, favorable seasonality, and investor optimism. However, the current environment of mixed economic data and rising policy uncertainty suggests that short-term volatility may persist. Broader Context Recent data highlights a steady but moderating US economy, while forward-looking risks remain: - **Global Economic Outlook:** The S&P Global forecast projects global GDP growth of approximately 3% by 2025, with US growth slowing to below 2% next year and China toward 4%. - **US Policy Risks:** Potential policy changes under the new administration could elevate inflation pressures and tighten financial conditions, introducing further uncertainty for equity markets. Implications for Nasdaq Supportive seasonality and the potential for a December rate cut may provide short-term stability. However, investors should remain cautious as geopolitical risks and economic uncertainties could lead to continued market volatility. What’s your outlook for the Nasdaq after today’s recovery? Can the index build on these gains, or will headwinds from economic data and global risks limit its upside? Share your thoughts in the comments!
CAPITALCOM:US100Long
by InvestMate